Experimental GLP-1 pill helped people with obesity lose weight, Eli Lilly says
By Amanda Sealy, CNN (CNN) — In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks. Lilly, which makes the injectable drugs Zepbound to treat obesity and Mounjaro and
Continue Reading